All News

Data scientists ID potential vulnerabilities in the COVID-19 virus

Ref: Newswise

Tags: Press Release 2019-nCoV Immunisation Clinical Research (R&D)

Patients With Crohn’s Disease With Inadequate Response to Upadacitinib Benefit From Dose Escalation

Tags: Conference Dispatch upadacitinib

Cerebral Blood Flow Velocity Predicts Outcomes Following Subarachnoid Haemorrhage

Tags: Conference Dispatch

XELJANZ (tofacitinib): Important Safety Information from Pfizer Healthcare Ireland as approved by the HPRA

Ref: HPRA

Tags: Press Release Pfizer European Union HPRA Regulatory Affairs Xeljanz

Viriom to present results of Phase I study of the long acting injectable formulation of novel NNRTi for treatment of HIV-1 infection at CROI 2020

Ref: PR Newswire

Tags: Press Release Viriom AIDS and HIV Clinical Research (R&D) Medical Affairs CROI VM1500-LAI

Drug Shortage in Mexico Piles Woes on Cancer-Stricken Children

Ref: The Wall Street Journal

Tags: NewsPoints PiSA Farmaceutica Marketing & Sales methotrexate

Recardio Completes Interim Analysis of Phase 2 in AMI

Ref: PR Newswire

Tags: Press Release Recardio Angina Pectoris/MI Clinical Research (R&D)dutogliptin

Advancing an oral drug for pulmonary arterial hypertension

Ref: University of Pennsylvania

Tags: Press Release Pulmonary Hypertension Clinical Research (R&D)

No Differences in Mortality Between Mechanically Ventilated Patients Receiving No Sedation vs Light Sedation

Tags: Conference Dispatch

Oncodesign and Servier reach a key first milestone in their strategic partnership on LRRK2 inhibitors for Parkinson’s Disease

Ref: Servier

Tags: Press Release Oncodesign Servier Parkinson's Clinical Research (R&D) Corporate Affairs